Can a stricter glucose goal improve diabetes control in children?

NCT ID NCT07376850

Not yet recruiting Disease control Sponsor: University Hospital, Motol Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study will enroll 120 children and teens with type 1 diabetes who use automated insulin pumps. Participants will be randomly assigned to follow either the standard blood sugar target (70-180 mg/dL) or a tighter target (70-140 mg/dL) for 12 months. Researchers want to see if the tighter range leads to better overall glucose control without increasing low blood sugar episodes or stress on families.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Structured diabetes education on two different glucose targets (Time in Range vs. Time in Normal Glycemia)
What this could lead to: If successful, this could show that a tighter glucose target is safe and effective for children with type 1 diabetes, potentially updating clinical guidelines worldwide.
What could go wrong: This is a relatively small, early-stage study (120 participants) comparing two educational approaches, not testing a new drug or device. The tighter target may increase hypoglycemia risk or family stress without clear benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES DIABETES (DM) DIABETES TYPE 1

Contacts and locations

Locations

Medical University of Warsaw

Warsaw, Poland
Motol University Hospital

Prague, Czechia
Schneider Children's Medical Center of Israel

Petah Tikva, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.